Correlation between HbA1c levels and intrastent restenosis incidence in patients with diabetes mellitus after percutaneous coronary intervention at Dr. Saiful Anwar General Hospital

Hayla Iqda Millisani, Indra Prasetya, Mohammad Saifur Rohman

Abstract


Background: Patients with chronic uncontrolled diabetes mellitus as indicated by HbA1c levels ≥ 6.5%, increase the risk of atherosclerosis, thereby increasing in-stent restenosis incidence during and after percutenous coronary intervention. Regular monitoring of HbA1c is crucial to reduce the incidence of in-stent restenosis.

Objective: This study aims to ascertain the correlation between HbA1c levels and in-stent restenosis incidence in diabetes mellitus patients after percutenous coronary intervention at Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia.

Methods/Design: Analytical observational study with a retrospective cohort study approach to determine the correlation between HbA1c levels and the incidence of in-stent restenosis in patients with diabetes mellitus after percutenous coronary intervention. The research sample was carried out by consecutive sampling in January 2021-December 2023.

Results: This study has recruited 555 patients with coronary artery disease and diabetes mellitus. The average age of coronary heart disease patients with diabetes mellitus was 59 years. Patients with HbA1c levels ≥6.5 were more prone to experience in-stent restenosis 54 patients, while those with HbA1c levels <6.5 were more prone not to experience in-stent restenosis 388 patients, indicating a significant correlation between HbA1c and in-stent restenosis p=0.024. in-stent restenosis was most frequently observed in the LAD 44 patients, RCA 13 patients, LCx 10 patients, and LM 0 patient. The highest percentage of in-stent restenosis cases was over 70%, with 3VD lesions being the most common 55 patients. OAD therapy is most often given to coronary heart disease patients with diabetes mellitus

Conclusion: There is a correlation between HbA1c levels and the incidence of in-stent restenosis in diabetes mellitus patients after percutaneous coronary intervention, underscoring the necessity for routine blood glucose monitoring to prevent in-stent restenosis.


Keywords


HbA1c, Intrastent Restenosis, Diabetes Mellitus, Percutaneous Coronary Intervention.

Full Text:

PDF

References


Bittl JA. Percutaneous Coronary Interventions in the Diabetic Patient. Circ Cardiovasc Interv. 2015;8(4). doi:10.1161/CIRCINTERVENTIONS.114.001944

Wilson S, Mone P, Kansakar U, Jankauskas SS, Donkor K, Adebayo A, et al. Diabetes and restenosis. Cardiovasc Diabetol. 2022;21(1). doi:10.1186/s12933-022-01460-5

Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, et al. Coronary In-Stent Restenosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;80(4):348-372. doi:10.1016/j.jacc.2022.05.017

Baber U, Stefanini GG, Giustino G, Stone GW, Leon MB, Sartori S, Aquino M, Steg PG, Windecker S, Wijns W, Serruys PW. Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis. Circulation: Cardiovascular Interventions. 2019 Jul;12(7):e007734.

Nusca A, Piccirillo F, Bernardini F, Filippis A De, Coletti F, Mangiacapra F, et al. Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data. Int J Mol Sci. 2022;23(13). doi:10.3390/ijms23137261

Śliwińska-Mossoń M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diabetes and Vascular Disease Research. 2017 Jul;14(4):265-76.

Tocci G, Barbato E, Coluccia R, Modestino A, Pagliaro B, Mastromarino V, Giovannelli F, Berni A, Volpe M. Blood pressure levels at the time of percutaneous coronary revascularization and risk of coronary in-stent restenosis. American Journal of Hypertension. 2016 Apr 1;29(4):509-18.

Bajeu IT, Niculescu AG, Scafa-Udriște A, Andronescu E. In-stent restenosis: a comprehensive review. International Journal of Molecular Sciences. 2024 Jan 30;25(3):1715.

Wang JL, Qin Z, Wang ZJ, Shi DM, Liu YY, Zhao YX, Yang LX, Cheng WJ, Zhou YJ. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent. Journal of Geriatric Cardiology: JGC. 2018 Feb;15(2):137.

Qin SY, Zhou Y, Jiang HX, Hu BL, Tao L, Xie MZ. The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis. PloS one. 2013 Sep 16;8(9):e72710.

Alexandrescu DM, Mitu O, Costache II, Macovei L, Mitu I, Alexandrescu A, Georgescu CA. Risk factors associated with intra-stent restenosis after percutaneous coronary intervention. Experimental and Therapeutic Medicine. 2021 Oct;22(4):1141.

Khan AU, Akbar F, Ullah S, Zeb H. Frequency of In-Stent Restenosis (ISR) in Diabetic Patients Following Percutaneous Coronary Intervention (PCI) for Stable Coronary Artery Disease (CAD) with Angina Pectoris Class III. Journal of Health and Rehabilitation Research. 2024 May 8;4(2):567-71.

Yi M, Tang WH, Xu S, Ke X, Liu Q. Investigation into the risk factors related to in-stent restenosis in elderly patients with coronary heart disease and type 2 diabetes within 2 years after the first drug-eluting stent implantation. Frontiers in Cardiovascular Medicine. 2022 May 20;9:837330.

Song L, Mintz GS, Yin D, Yamamoto MH, Chin CY, Matsumura M, Kirtane AJ, Parikh MA, Moses JW, Ali ZA, Shlofmitz RA. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study. EuroIntervention. 2017 Jun 1;13(3):294-302.

Patil S, Chatterjee M, Setty N, Jadhav S. Clinical Profile and Angiographic Patterns of Patients Undergoing Treatment for In-stent Restenosis and Outcomes Associated with the Treatment. Research in Cardiovascular Medicine. 2020 Jul 1;9(3):55-60.

Bai J, Wang HX, Wang JT, Zhao J, Peng L, Yang XD, Tang Z, Nazneen S, Wang GK, Wang Y. Successful opening in-stent chronic total occlusion lesion of coronary artery by excimer laser coronary angioplasty. Journal of Geriatric Cardiology: JGC. 2019 Jun;16(6):502.

Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. Journal of Thoracic Disease. 2016;8(10): E1150-E1162

Ullrich H, Olschewski M, Munzel T, Gori T. Coronary In-Stent Restenosis: Predictors and Treatment. Dtsch Arztebl Int. 2021; 118: 637-44




DOI: https://doi.org/10.21776/ub.hsj.2024.005.04.10

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Hayla Iqda Millisani

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.